KR970073582A - Treatment of rheumatic diseases containing paclitaxel - Google Patents

Treatment of rheumatic diseases containing paclitaxel Download PDF

Info

Publication number
KR970073582A
KR970073582A KR1019960014189A KR19960014189A KR970073582A KR 970073582 A KR970073582 A KR 970073582A KR 1019960014189 A KR1019960014189 A KR 1019960014189A KR 19960014189 A KR19960014189 A KR 19960014189A KR 970073582 A KR970073582 A KR 970073582A
Authority
KR
South Korea
Prior art keywords
therapeutic agent
treatment
containing paclitaxel
rheumatic diseases
diseases containing
Prior art date
Application number
KR1019960014189A
Other languages
Korean (ko)
Other versions
KR100191446B1 (en
Inventor
송영욱
홍경만
정은숙
Original Assignee
송영욱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 송영욱 filed Critical 송영욱
Priority to KR1019960014189A priority Critical patent/KR100191446B1/en
Priority to AU73413/96A priority patent/AU7341396A/en
Priority to PCT/KR1996/000183 priority patent/WO1997041850A1/en
Publication of KR970073582A publication Critical patent/KR970073582A/en
Application granted granted Critical
Publication of KR100191446B1 publication Critical patent/KR100191446B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

본 발명은 전신성 류마티스성 질환, 이중 치사율이 높은 것으로 알려진 전신성 홍반성 낭창 치료에 유용한 약제로서 파클리탁셀을 유효성분으로 함유하는 치료제에 관한 것이다. 본 발명의 치료제는 주사제 제형인 것이 바람직하다.The present invention relates to a therapeutic agent containing paclitaxel as an active ingredient as a medicament useful for the treatment of systemic lupus erythematosis, which is known to have a high systemic rheumatic disease and a high double mortality rate. The therapeutic agent of the present invention is preferably an injection preparation.

Description

파클리탁셀 함유 류마티스성 질환 치료제Treatment of rheumatic diseases containing paclitaxel

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is a trivial issue, I did not include the contents of the text.

Claims (3)

파클리탁셀을 유효성분으로 함유하는 류마티스성 질환 치료제.A therapeutic agent for a rheumatic disease containing paclitaxel as an active ingredient. 제1항에 있어서, 상기 류마티스성 질환이 전신성 홍반성 낭창임을 특징으로 하는 치료제.The therapeutic agent according to claim 1, wherein the rheumatic disease is systemic lupus erythematosus. 제1항에 있어서, 상기 치료제가 주사제 제형임을 특징으로 하는 치료제.2. The therapeutic agent according to claim 1, wherein the therapeutic agent is an injectable formulation. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: It is disclosed by the contents of the first application.
KR1019960014189A 1996-05-02 1996-05-02 Agent cotaining paclitaxel for the treatment of system lupous erythematosus KR100191446B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1019960014189A KR100191446B1 (en) 1996-05-02 1996-05-02 Agent cotaining paclitaxel for the treatment of system lupous erythematosus
AU73413/96A AU7341396A (en) 1996-05-02 1996-10-26 Paclitaxel for the treatment of rheumatic diseases
PCT/KR1996/000183 WO1997041850A1 (en) 1996-05-02 1996-10-26 Paclitaxel for the treatment of rheumatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960014189A KR100191446B1 (en) 1996-05-02 1996-05-02 Agent cotaining paclitaxel for the treatment of system lupous erythematosus

Publications (2)

Publication Number Publication Date
KR970073582A true KR970073582A (en) 1997-12-10
KR100191446B1 KR100191446B1 (en) 1999-06-15

Family

ID=19457526

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960014189A KR100191446B1 (en) 1996-05-02 1996-05-02 Agent cotaining paclitaxel for the treatment of system lupous erythematosus

Country Status (3)

Country Link
KR (1) KR100191446B1 (en)
AU (1) AU7341396A (en)
WO (1) WO1997041850A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (en) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa NEW PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE TAXANE CLASS.
KR100371062B1 (en) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 Injectable taxi brush compositions with improved stability and methods of formulating them
US5631278A (en) * 1992-12-02 1997-05-20 Thomas Jefferson University Methods of killing protozoal parasites
FR2698543B1 (en) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa New taxoid-based compositions.

Also Published As

Publication number Publication date
WO1997041850A1 (en) 1997-11-13
KR100191446B1 (en) 1999-06-15
AU7341396A (en) 1997-11-26

Similar Documents

Publication Publication Date Title
KR920019342A (en) Bone Disease Treatment
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
KR890000101A (en) How to improve the treatment of banwol tissue and therapeutic drugs
KR890015742A (en) Topical preparations for the treatment of diseases
KR950031060A (en) Pharmaceutical composition for the treatment of osteoporosis
KR970025615A (en) Cancer metastasis inhibitor
MX9400801A (en) TETRAHIDROPIRIDINNA O-SUBSTITUTED OXYM COLLERGIC AGENTS STABILIZED WITH STARCH.
BR0309057A (en) Low dosage liquid formulations in entecavir and use
KR930019224A (en) Abortion Hazard Remedy
KR970073582A (en) Treatment of rheumatic diseases containing paclitaxel
KR970704442A (en) (S) -adenosyl-L-methionine (SAMe) and its physiologically compatible salts for the treatment of reperfusion injury induced by transient lesion ischemia (Use of (S) -Adenosy-L-Methionine Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
KR910004186A (en) Pharmaceutical Formulations
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety
KR910004190A (en) New medical uses of ondansetron
ATE355825T1 (en) STRUCTURED EMULSION CONTAINING AMPHOTERICIN B
KR960003717A (en) Use of elliprodil and its enantiomers for the manufacture of a medicament useful for the prevention of peripheral neuropathy caused by anticancer agents
KR950007852A (en) Arthritis treatment containing uracil as an active ingredient
ATE223700T1 (en) NEW INJECTABLE MEDICINAL PREPARATIONS CONTAINING RAMOPLAN
KR910000106A (en) Hair growth promoter
KR930702016A (en) Osteoporosis Drug
KR910021244A (en) Diabetic Necrotic Medication
KR920016104A (en) Topical Use of Calcitonin for the Preparation of Idiopathic Idiopathic Cataract Drugs and Their Pharmaceutical Compositions
KR930007451A (en) Arthritis treatment containing uridine as an active ingredient
KR930019216A (en) Tumor treatment
KR890001543A (en) Diabetes treatment

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
O035 Opposition [patent]: request for opposition
O132 Decision on opposition [patent]
O074 Maintenance of registration after opposition [patent]: final registration of opposition
FPAY Annual fee payment

Payment date: 20110104

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee